• 제목/요약/키워드: integrative treatment

검색결과 719건 처리시간 0.024초

IMMUNIES, a unique polyherbal extract, exhibits antiproliferative activity and improves tumor-bearing canine patients: a pilot study

  • Won Seok Oh;Ilju Kim;Jiyoung Moon;Seung Joon Baek
    • Journal of Applied Biological Chemistry
    • /
    • 제66권
    • /
    • pp.379-387
    • /
    • 2023
  • Dog owners seek treatment when their pets develop cancer. IMMUNIES is traditional herbal medicine-based figment made of 10 natural herbs, designed to maintain host immune function. The major component of IMMUNIES is Dendropanax morbiferus. This clinical pilot study monitored the toxicity and efficacy of IMMUNIES. Four senile dogs with spontaneously occurring mammary and liver cancers were enrolled in this study and treated orally daily for 3 months, and their blood/urine biochemical profiles were examined each month. IMMUNIES was well tolerated during the treatment period. Blood urea nitrogen, creatinine, alanine aminotransferase, alkaline phosphatase, and C-reactive protein levels decreased in all four dogs, whereas red blood cells and hematocrit were within the normal range. IMMUNIES also changed the expression of several molecular targets in the anticancer pathway, such as pro-NAG-1, p53, and cyclin D1. Although the tumors did not completely respond to IMMUNIES, the biochemical profiles and clinical examination showed a stabilized cancer status for 3 months. Thus, IMMUNIES was found to be safe and well-tolerated in the dosage range tested and exhibited cancer antiproliferative activity in canine cancer. Future studies should address other potential benefits of IMMUNIES, including correlative assessments of immune function, quality of life, and owner satisfaction.

고유-전정감각 중심의 감각통합 중재가 감각방어 아동의 적응반응에 미치는 효과: 사례보고 (The Effect of Sensory Integrative Intervention Focused on Proprioceptive-Vestibular Stimuli on Adaptive Response of Children With Sensory Defensiveness: Case Study)

  • 박지훈;김인선
    • 대한감각통합치료학회지
    • /
    • 제9권2호
    • /
    • pp.29-39
    • /
    • 2011
  • 목적 : 본 연구는 고유-전정감각 중심의 감각통합중재가 감각방어를 가진 아동의 적응반응에 미치는 효과를 알아보고자 하였다. 연구방법 : 연구 대상은 2011년 감각통합치료과정에 참여한 만 6세 5개월 된 남아이다. 평가결과에 따라 치료목표, 치료계획을 제시하였고, 4회기 동안의 적응반응을 기술하였다. 결과 : 치료회기 동안 아동은 과 각성 되지 않고 촉각활동에 참여할 수 있었으며, 사회적 상호작용의 질적인 측면에서 향상을 보였고, 놀이에서도 확장을 보였다. 결론 : 본 연구를 통하여 고유-전정감각 중심의 감각통합 중재가 감각방어 아동의 적응반응에 긍정적인 영향을 미치는 것을 알 수 있었다. 그러나 향후 연구에서는 표준화된 평가를 통한 변화와 더불어 일상에서의 변화를 제시하는 것이 필요할 것으로 사료된다.

  • PDF

보이타 치료중재가 뇌성마비아동의 근활성화 및 발성에 미치는 효과 (The Effects of Vojta's Treatment on Respiratory Muscle Activity and Phonation in children with Spastic Cerebral Palsy)

  • 주기찬;이효정
    • 대한통합의학회지
    • /
    • 제1권3호
    • /
    • pp.37-49
    • /
    • 2013
  • Purpose : The purpose of this study was to evaluate the influence of Respiratory Capacity by Vojta's treatment in children with spastic cerebral palsy. Method : The subjects of this study, children diagnosed with spastic cerebral palsy, 12 patients were picked up, who were agreed with this research and were having hospital care for 4weeks at MH and PR medical centers. Result : In comparison of Respiratory muscle activity and Phonation capacity were significant in the group(p<.01) and MPT and Rectus abd(Rt) were significantly correlated in the pre test and SMR and Ex/oblique (Lt) were significantly correlated in the post test. Conclusion : Therefore, the Vojta's treatment is useful to improve the Respiratory muscle activity and Phonation capacity in children with spastic cerebral palsy.

Tumor antigen PRAME is a potential therapeutic target of p53 activation in melanoma cells

  • Yong-Kyu Lee;Hyeon Ho Heo;Nackhyoung Kim;Ui-Hyun Park;Hyesook Youn;Eun-Yi Moon;Eun-Joo Kim;Soo-Jong Um
    • BMB Reports
    • /
    • 제57권6호
    • /
    • pp.299-304
    • /
    • 2024
  • Upregulation of PRAME (preferentially expressed antigen of melanoma) has been implicated in the progression of a variety of cancers, including melanoma. The tumor suppressor p53 is a transcriptional regulator that mediates cell cycle arrest and apoptosis in response to stress signals. Here, we report that PRAME is a novel repressive target of p53. This was supported by analysis of melanoma cell lines carrying wild-type p53 and human melanoma databases. mRNA expression of PRAME was downregulated by p53 overexpression and activation using DNA-damaging agents, but upregulated by p53 depletion. We identified a p53-responsive element (p53RE) in the promoter region of PRAME. Luciferase and ChIP assays showed that p53 represses the transcriptional activity of the PRAME promoter and is recruited to the p53RE together with HDAC1 upon etoposide treatment. The functional significance of p53 activation-mediated PRAME downregulation was demonstrated by measuring colony formation and p27 expression in melanoma cells. These data suggest that p53 activation, which leads to PRAME downregulation, could be a therapeutic strategy in melanoma cells.

쑥뜸치료(Moxibustion)로 호전된 비소세포성 폐암 환자의 암성 통증 1례 (A Clinical Case of Patient with Cancer Pain Treated by Moxibustion)

  • 김민경;이진수;이상헌;정현식;최원철;김경석
    • 대한암한의학회지
    • /
    • 제14권1호
    • /
    • pp.53-59
    • /
    • 2009
  • Background & Objective: Regardless of types of cancer, cancer pain means the pain occurred by tumor itself, caused by complication or side effects during treatment and which is neither directly related to tumor nor treatment. This case was performed to relieve the cancer pain and study the effect of moxibustion to the cancer pain. Method: For 27 days, the patient was treated by moxibustion($MANINA^{(R)}$), acupuncture, herbal medicine and narcotic analgesics. We planned to maintain moxibustion on 8 points of Bladder meridian line(BL13, BL17, BL42, BL43) for 20 minutes. The improvement of the symptom was evaluated by BPI/VAS, and the amount of narcotic analgesics applied. Results: The BPI/VAS was declined and amount of applying narcotic analgesics was decreased. Conclusion: It is suggested that moxibustion on BL13, BL17, BL42, BL43 is useful to relief of cancer pain in left flank area.

  • PDF

알러젠 제거 옻나무 추출물 위주의 한방치료와 항암화학요법을 병용한 폐암 환자 2례 (Two Cases of Non-small Cell Lung Cancer Patients Treated with Allergen Removed Rhus Verniciflua Stokes Based Traditional Korean Medicine and Chemotherapy)

  • 권은미;정의민;김경석;이수경;최원철;윤성우
    • 대한암한의학회지
    • /
    • 제14권1호
    • /
    • pp.13-20
    • /
    • 2009
  • Lung cancer remains the leading cause of cancer-related death throughout the world. Non-small cell lung cancer(NSCLC) is the most deadly form of lung cancer. Patients with non-small cell lung cancer are often found to be unavailable for operation at primary diagnosis. They are typically given conventional chemotherapy. When the tumor progresses during chemotherapy, a change in regimen is considered. The average period of administration differs with the regimen. In this case report, the authors introduce two cases of non-small cell lung cancer patients treated with allergen removed Rhus verniciflua stokes based herbal medicine along with pemetrexed($Alimta^{(R)}$) and erlotinib($Tarceva^{(R)}$). The authors report this case because these molecular-targeted agents were used for longer periods than expected, while improving the performance and other symptoms. Further studies illuminating the synergistic effects through conjunctive treatment with both conventional and Eastern medicine in lung cancer treatment should be performed in the future.

  • PDF

AKT1-targeted proapoptotic activity of compound K in human breast cancer cells

  • Choi, Eunju;Kim, Eunji;Kim, Ji Hye;Yoon, Keejung;Kim, Sunggyu;Lee, Jongsung;Cho, Jae Youl
    • Journal of Ginseng Research
    • /
    • 제43권4호
    • /
    • pp.692-698
    • /
    • 2019
  • Background: Breast cancer is a severe disease and the second leading cause of cancer death in women worldwide. To surmount this, various diagnosis and treatment options for breast cancer have been developed. One of the most effective strategies for cancer treatment is to induce apoptosis using naturally occurring compounds. Compound K (CK) is a ginseng saponin metabolite generated by human intestinal bacteria. CK has been studied for its cardioprotective, antiinflammatory, and liver-protective effects; however, the role of CK in breast cancer is not fully understood. Methods: To investigate the anticancer effects of CK in SKBR3 and MDA-MB-231 cells, cell viability assays and flow cytometry analysis were used. In addition, the direct targets of CK anticancer activity were identified using immunoblotting analysis and overexpression experiments. Invasion, migration, and clonogenic assays were carried out to determine the effects of CK on cancer metastasis. Results: CK-induced cell apoptosis in SKBR3 cells as determined through 3-(4-5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide assays, propidium iodide (PI) and annexin V staining, and morphological changes. CK increased the cleaved forms of caspase-7, caspase-8, and caspase-9, whereas the expression of Bcl-2 was reduced by CK. In assays probing the cell survival pathway, CK activated only AKT1 and not AKT2. Moreover, CK inhibited breast cancer cell invasion, migration, and colony formation. Through regulation of AKT1 activity, CK exerts anticancer effects by inducing apoptosis. Conclusion: Our results suggest that CK could be used as a therapeutic compound for breast cancer.

알러젠 제거(除去) 옻나무 추출물(抽出物) 투여(投與)로 호전(好轉)된 유방암(乳房癌) 환자 1례 (A case of breast cancer Patient Treated with Allergen Removed Rhus Verniciflua Stokes(ARV))

  • 김초영;박재우;정현식;최원철;윤성우
    • 대한암한의학회지
    • /
    • 제12권1호
    • /
    • pp.67-73
    • /
    • 2007
  • Breast cancer is common in West and Incidence of breast cancer has increased in Korea. According as conventional western medical treatment, breast cancer patient received MRM(modified radical mastectomy) and anti cancer chemotherapy. In this case report, We introduce a case of breast cancer patient who showed lung metastasis(metastatec adenocarcinoma) after MRM(modified radical mastectomy) 4 years before the diagnosis of relapse. After lung metastasis of breast cancer, the patient received 4th chemotherapy and refused to get more conventional western medical treatment including chemotherapy. After 24 month of traditional oriental medical treatment using allegen removed Rhus Verniciflua Stokes(ARV), however, the size of cancer mass decreased and the patient showed improved condition. Further case study will be needed in order to determine the effect of ARV on breast cancer patient.

  • PDF

통합적인 한방치료로 호전된 복합부위통증증후군(CRPS) type1 환자 1례 보고 (A Case Report of a Patient Diagnosed with Complex Regional Pain Syndrome (Type 1) Improved by Integrative Korean Medical Treatment)

  • 김수연;김석우;하도형;김수연;김은정
    • 대한한방내과학회지
    • /
    • 제39권5호
    • /
    • pp.895-903
    • /
    • 2018
  • Objectives: This study reports on the efficacy of using integrative Korean medical treatments for Type 1 complex regional pain syndrome (CRPS). Methods: A 48-year-old female patient with Type 1 R/O CRPS was treated with herbal medicines, acupuncture, and pharmacopuncture for 38 days. The chief complaints were severe burning pain, general weakness, sleep disorder, and aggressive and depressed mood. The treatment effect was evaluated by measuring the numerical rating scale (NRS) of pain, improvement of the quality of sleep, and change in mood status. Results: After the hospital treatment, the patient's pain was controlled and the NRS score was decreased. Sleep and mood disorder also improved. Conclusions: The integrative Korean medical treatments appeared to be effective in reducing Type 1 CRPS symptoms. Further clinical research of patients with CRPS is needed.

전이성 평활근육종 환자의 통합 암 치료에 대한 증례보고 (A Case Report of Metastatic Leiomyosarcoma Patient Treated with Integrative Cancer Treatment)

  • 송시연;장혁준;박소정;전형준;이연월;조종관;유화승
    • 대한암한의학회지
    • /
    • 제24권1호
    • /
    • pp.11-18
    • /
    • 2019
  • Objective: The purpose of this study is to report the effectiveness and possibility of Integrative Cancer Treatment (ICT) on an advanced metastatic leiomyosarcoma patient. Methods: The patient was diagnosed with recurred and advanced metastatic Leiomyosarcoma, suffering from dyspnea, abdominal discomfort, lower limb edema. The patient refused conventional treatment, such as chemotherapy, radiotherapy but was treated with ICT including acupuncture, pharmacopuncture, moxibustion, hypertherapy and herbal medicine for symptom management. The clinical outcomes were measured by NRS (Numeral rating scale). Results: After treatment, dyspnea, abdominal discomfort and lower limb edema was relieved from NRS 6 to 3, 7 to 3 and 7 to 6 respectively. Also, loss of body weight, decrease in abdominal, thigh and calf circumference were improved. During and after treatment, we found neither hepatotoxicity nor nephrotoxicity on laboratory findings. Conclusion: This case study suggests that ICT may improve symptom relief and life quality of leiomyosarcoma patient.